Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMN 110 in children under 5 years with Morquio A syndrome
2011-003197-84Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical Inc.
- Start
- Sep 2011
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of elosulfase alfa in Mucopolysaccharidosis type IV A, sponsored by BioMarin Pharmaceutical Inc. Started Sep 2011; status: completed.
02
Drugs
elosulfase alfa
03
Conditions
Mucopolysaccharidosis type IV A
Beyond the preview
Go deeper on 2011-003197-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003197-84.